Trials / Conditions / Stage II-III Non-small Cell Lung Cancer
Stage II-III Non-small Cell Lung Cancer
4 registered clinical trials studyying Stage II-III Non-small Cell Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Pati NCT06437977 | Shanghai Chest Hospital | Phase 3 |
| Recruiting | Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection NCT07131163 | Sheba Medical Center | — |
| Active Not Recruiting | Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC NCT04158440 | Shanghai Junshi Bioscience Co., Ltd. | Phase 3 |
| Completed | Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC NCT06958614 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |